Phase 1 dose escalating and pharmacokinetic (PK) study of KOS-862 (epothilone D): Phase 2 dose and schedule defined Meeting Abstract


Authors: Spriggs, D.; Dupont, J.; Pezzulli, S.; Larkin, J.; Cropp, G.; Johnson, R.; Hannah, A. L.
Abstract Title: Phase 1 dose escalating and pharmacokinetic (PK) study of KOS-862 (epothilone D): Phase 2 dose and schedule defined
Meeting Title: 2003 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Journal Title: Clinical Cancer Research
Volume: 9
Issue: 16 Pt. 2
Meeting Dates: 2003 Nov 17-21
Meeting Location: Boston, MA
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2003-12-01
Start Page: 6129s
End Page: 6130s
Language: English
ACCESSION: WOS:000187467300247
PROVIDER: wos
PUBMED: 14712828
Notes: Meeting Abstract: #A248 -- Poster Session A -- Source: Wos
Citation Impact
MSK Authors
  1. Jakob Dupont
    65 Dupont
  2. David R Spriggs
    325 Spriggs
  3. Joseph M Larkin
    8 Larkin
Related MSK Work